These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27871332)

  • 1. The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol.
    Khaled SM; Hughes E; Bressington D; Zolezzi M; Radwan A; Badnapurkar A; Gray R
    Syst Rev; 2016 Nov; 5(1):195. PubMed ID: 27871332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of the effects of novel psychoactive substances 'legal highs' on people with severe mental illness.
    Gray R; Bressington D; Hughes E; Ivanecka A
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):267-81. PubMed ID: 27037639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web.
    Corazza O; Valeriani G; Bersani FS; Corkery J; Martinotti G; Bersani G; Schifano F
    J Psychoactive Drugs; 2014; 46(4):287-94. PubMed ID: 25188698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New psychoactive substances: Current health-related practices and challenges in responding to use and harms in Europe.
    Pirona A; Bo A; Hedrich D; Ferri M; van Gelder N; Giraudon I; Montanari L; Simon R; Mounteney J
    Int J Drug Policy; 2017 Feb; 40():84-92. PubMed ID: 27956184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel psychoactive substances: What educators need to know.
    Patterson ZR; Young MM; Vaccarino FJ
    Clin Pharmacol Ther; 2017 Feb; 101(2):173-175. PubMed ID: 27756105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP).
    Wood DM; Dargan PI
    Clin Toxicol (Phila); 2012 Sep; 50(8):727-32. PubMed ID: 22882169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of new psychoactive substances in Northeast Asia from 2007 to 2015.
    Lee J; Yang S; Kang Y; Han E; Feng LY; Li JH; Chung H
    Forensic Sci Int; 2017 Mar; 272():1-9. PubMed ID: 28088088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies.
    Assi S; Gulyamova N; Ibrahim K; Kneller P; Osselton D
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28631432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
    Zawilska JB; Andrzejczak D
    Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current challenges and problems in the field of new psychoactive substances in Germany from a law enforcement perspective.
    Duffert A
    Drug Test Anal; 2014; 6(7-8):876-8. PubMed ID: 24415657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New psychoactive substances and their prevalence in the Czech Republic].
    Mravčík V; Běláčková V; Grohmannová K; Zábranský T
    Cas Lek Cesk; 2015; 154(5):216-21. PubMed ID: 26612328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans.
    Nugteren-van Lonkhuyzen JJ; van Riel AJ; Brunt TM; Hondebrink L
    Drug Alcohol Depend; 2015 Dec; 157():18-27. PubMed ID: 26530501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing misuse of novel psychoactive substances.
    Solomon D; Grewal P; Taylor C; Solomon B
    Nurs Times; 2014 May 28-Jun 3; 110(22):12-5. PubMed ID: 24984370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Psychoactive Substances (NPS) - the Hydra monster of recreational drugs.
    Helander A; Bäckberg M
    Clin Toxicol (Phila); 2017 Jan; 55(1):1-3. PubMed ID: 27549399
    [No Abstract]   [Full Text] [Related]  

  • 15. From concept(ion) to life after death/the grave: The 'natural' history and life cycle(s) of novel psychoactive substances (NPS).
    Corkery JM; Orsolini L; Papanti D; Schifano F
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are government-approved products containing new psychoactive substances perceived to be safer and more socially acceptable than alcohol, tobacco and illegal drugs? Findings from a survey of police arrestees in New Zealand.
    Rychert M; Wilkins C; Parker K; Witten K
    Drug Alcohol Rev; 2018 Mar; 37(3):406-413. PubMed ID: 29285812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.
    Evans-Brown M; Sedefov R
    Handb Exp Pharmacol; 2018; 252():3-49. PubMed ID: 30194542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Presence of New Psychoactive Substances in a Tor Network Marketplace Environment.
    Dolliver DS; Kuhns JB
    J Psychoactive Drugs; 2016; 48(5):321-329. PubMed ID: 27660913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel psychoactive substance poses a new challenge in the management of paranoid schizophrenia.
    Anderson C; Morrell C; Marchevsky D
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25948854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
    Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.